CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
May 8th 2025
I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, laughter and a community of hope.
Kisqali Granted Breakthrough Therapy Designation for Breast Cancer Subset
January 4th 2018Kisqali (ribociclib) was granted a breakthrough therapy designation by the Food and Drug Administration (FDA) to be used in combination with tamoxifen or an aromatase inhibitor (AI) in the frontline treatment of pre- or perimenopausal women who have hormone receptor-positive HER2-negative advanced or metastatic breast cancer.
Facing the Responsibilities of the New Year
December 29th 2017The new year impacts breast cancer survivors in a vastly different ways than it does most people. Our resolutions, especially health-related resolutions, can be detrimental to our health if we don't keep them. This survivor shares her own chagrin at failing to keep some promises.
Perjeta Combination Granted FDA Approval for Breast Cancer
December 21st 2017The FDA has approved Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy as an adjuvant treatment for patients with HER2-positive early breast cancer at high risk for recurrence, based on findings from the APHINITY trial.